MYnd Analytics: Jumps as FDA grants breakthrough device label

Emmaus Life Sciences

17/09/2018 14:43

** Healthcare analytics provider's shares  MYND.O  jumps 24
pct to $2.24 - erasing losses for last 3-months
    ** Co's device PEER 4.0 gets breakthrough device designation
from U.S. FDA  urn:newsml:reuters.com:*:nGNX4kjnt9
    ** PEER is a cloud-based database to predict how a patient
will respond to a specific medication
    ** Despite Monday's early gains, stock had fallen ~35 pct
this year

 (Reporting by Saumya Sibi Joseph in Bengaluru)
 ((saumya.joseph@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 80 6749 9379; Reuters Messaging:
saumya.joseph.thomsonreuters.com@reuters.net))